Literature DB >> 10449167

Immunobiology of DC in NOD mice.

P A Morel1, A C Vasquez, M Feili-Hariri.   

Abstract

NOD mice spontaneously develop diabetes between 15 and 20 weeks of age, which is preceded by insulitis characterized by the infiltration of lymphocytes. Dendritic cells (DC) are among the first cells to infiltrate the islet and they have been implicated in the pathogenesis of the disease. Our work has been concerned with the detailed characterization of four distinct DC populations in NOD mice: two derived from bone marrow (BM) cells cultured in either granulocyte-macrophage colony-stimulating factor (GM-CSF) plus interleukin-4 (IL-4) or GM-CSF alone and two from the spleen of Flt3 ligand (Flt3L) -treated mice, isolated on the basis of CD8alpha expression. Phenotypic and functional differences between these DC subsets in NOD mice have been identified. In addition, we obtained a lower yield of NOD BM-derived DC and they expressed higher levels of cell-surface CD40 and IL-12 p40 mRNA than BM-derived DC from the diabetes-resistant strain, B10.BR. We have also investigated the ability of these DC populations to modulate the development and progression of diabetes in NOD mice.

Entities:  

Mesh:

Year:  1999        PMID: 10449167     DOI: 10.1002/jlb.66.2.276

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  12 in total

1.  A defect in bone marrow derived dendritic cell maturation in the nonobesediabetic mouse.

Authors:  J Strid; L Lopes; J Marcinkiewicz; L Petrovska; B Nowak; B M Chain; T Lund
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

2.  Cutting edge: merocytic dendritic cells break T cell tolerance to beta cell antigens in nonobese diabetic mouse diabetes.

Authors:  Jonathan D Katz; Jennifer K Ondr; Robert J Opoka; Zacharias Garcia; Edith M Janssen
Journal:  J Immunol       Date:  2010-07-19       Impact factor: 5.422

3.  A cell-based microarray to investigate combinatorial effects of microparticle-encapsulated adjuvants on dendritic cell activation.

Authors:  Abhinav P Acharya; Matthew R Carstens; Jamal S Lewis; Natalia Dolgova; C Q Xia; Michael J Clare-Salzler; Benjamin G Keselowsky
Journal:  J Mater Chem B       Date:  2015-09-30       Impact factor: 6.331

4.  Antigen-dependent immunotherapy of non-obese diabetic mice with immature dendritic cells.

Authors:  C Haase; L Yu; G Eisenbarth; H Markholst
Journal:  Clin Exp Immunol       Date:  2010-02-18       Impact factor: 4.330

5.  Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cells.

Authors:  Thomas Enzler; Silke Gillessen; Michael Dougan; James P Allison; Donna Neuberg; Darryl A Oble; Martin Mihm; Glenn Dranoff
Journal:  Blood       Date:  2007-05-04       Impact factor: 22.113

6.  Passive transfer of flt-3L-derived dendritic cells delays diabetes development in NOD mice and associates with early production of interleukin (IL)-4 and IL-10 in the spleen of recipient mice.

Authors:  J Morin; B Faideau; M-C Gagnerault; F Lepault; C Boitard; S Boudaly
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

Review 7.  Immunomodulation of autoimmune diabetes by dendritic cells.

Authors:  Klaus Pechhold; Kerstin Koczwara
Journal:  Curr Diab Rep       Date:  2008-04       Impact factor: 4.810

8.  Rabbit polyclonal mouse antithymocyte globulin administration alters dendritic cell profile and function in NOD mice to suppress diabetogenic responses.

Authors:  Yanfei Huang; Matthew Parker; Changqing Xia; Ruihua Peng; Clive Wasserfall; Tracy Clarke; Lizhen Wu; Tayseer Chowdhry; Martha Campbell-Thompson; John Williams; Michael Clare-Salzler; Mark A Atkinson; Karl L Womer
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

9.  CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease.

Authors:  Husein Hadeiba; Tohru Sato; Aida Habtezion; Cecilia Oderup; Junliang Pan; Eugene C Butcher
Journal:  Nat Immunol       Date:  2008-10-05       Impact factor: 25.606

10.  Despite Increased Type 1 IFN, Autoimmune Nonobese Diabetic Mice Display Impaired Dendritic Cell Response to CpG and Decreased Nuclear Localization of IFN-Activated STAT1.

Authors:  M Jubayer Rahman; Gwendoline Rahir; Matthew B Dong; Yongge Zhao; Kameron B Rodrigues; Chie Hotta-Iwamura; Ye Chen; Alan Guerrero; Kristin V Tarbell
Journal:  J Immunol       Date:  2016-01-29       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.